2019
DOI: 10.1007/s12630-019-01551-0
|View full text |Cite
|
Sign up to set email alerts
|

Utilisation de l’épuration extra-corporelle de dioxyde de carbone dans l’exacerbation de la maladie pulmonaire obstructive chronique: une revue narrative

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 42 publications
0
2
0
Order By: Relevance
“…Such strategies should be based on the severity of patients, mainly assessed by parameters of dynamic hyperinflation and respiratory acidosis. Based on animal and clinical studies, clinicians should also take into account the performances of the different ECCO 2 R devices and their effects on native lungs respiratory CO 2 elimination [ 22 , 23 ]. Providing such strategies could have important implications for the care of patients and for the design of future RCTs aiming to prove important clinical benefits of ECCO 2 R in very severe AE-COPD patients.…”
Section: Discussionmentioning
confidence: 99%
“…Such strategies should be based on the severity of patients, mainly assessed by parameters of dynamic hyperinflation and respiratory acidosis. Based on animal and clinical studies, clinicians should also take into account the performances of the different ECCO 2 R devices and their effects on native lungs respiratory CO 2 elimination [ 22 , 23 ]. Providing such strategies could have important implications for the care of patients and for the design of future RCTs aiming to prove important clinical benefits of ECCO 2 R in very severe AE-COPD patients.…”
Section: Discussionmentioning
confidence: 99%
“…ECCO 2 R has been proposed to facilitate ultra-protective ventilation [ 2 , 3 , 4 ] and to promote non-invasive ventilation [ 5 ]. This could be particularly beneficial in patients suffering from respiratory failure, including exacerbations of chronic obstructive pulmonary disease (COPD) [ 6 ], acute respiratory distress syndrome (ARDS) [ 7 ], and patients awaiting lung transplantation [ 8 ]. The amount of CO 2 removed by the extracorporeal support is a crucial determinant of clinical efficacy [ 9 , 10 ].…”
Section: Introductionmentioning
confidence: 99%